nodes	percent_of_prediction	percent_of_DWPC	metapath
Maraviroc—CCR5—renal system—colon cancer	0.038	0.245	CbGeAlD
Maraviroc—CCR5—lymphoid tissue—colon cancer	0.0316	0.203	CbGeAlD
Maraviroc—CCR5—digestive system—colon cancer	0.0312	0.201	CbGeAlD
Maraviroc—CCR5—vagina—colon cancer	0.0275	0.177	CbGeAlD
Maraviroc—CCR5—lymph node—colon cancer	0.0178	0.115	CbGeAlD
Maraviroc—CYP3A4—renal system—colon cancer	0.00383	0.0247	CbGeAlD
Maraviroc—CYP3A4—digestive system—colon cancer	0.00314	0.0202	CbGeAlD
Maraviroc—CYP3A4—liver—colon cancer	0.00234	0.0151	CbGeAlD
Maraviroc—Agranulocytosis—Fluorouracil—colon cancer	0.00146	0.00173	CcSEcCtD
Maraviroc—Cerebrovascular accident—Capecitabine—colon cancer	0.00145	0.00171	CcSEcCtD
Maraviroc—Connective tissue disorder—Irinotecan—colon cancer	0.00144	0.00171	CcSEcCtD
Maraviroc—Rhinitis—Fluorouracil—colon cancer	0.00141	0.00167	CcSEcCtD
Maraviroc—Cardiac disorder—Vincristine—colon cancer	0.0014	0.00165	CcSEcCtD
Maraviroc—Pharyngitis—Fluorouracil—colon cancer	0.00139	0.00165	CcSEcCtD
Maraviroc—Angiopathy—Vincristine—colon cancer	0.00137	0.00162	CcSEcCtD
Maraviroc—Cardiac disorder—Irinotecan—colon cancer	0.00136	0.00161	CcSEcCtD
Maraviroc—Mediastinal disorder—Vincristine—colon cancer	0.00136	0.00161	CcSEcCtD
Maraviroc—Alopecia—Vincristine—colon cancer	0.00133	0.00157	CcSEcCtD
Maraviroc—Angiopathy—Irinotecan—colon cancer	0.00133	0.00157	CcSEcCtD
Maraviroc—Mediastinal disorder—Irinotecan—colon cancer	0.00132	0.00156	CcSEcCtD
Maraviroc—Mental disorder—Vincristine—colon cancer	0.00132	0.00156	CcSEcCtD
Maraviroc—Neoplasm—Methotrexate—colon cancer	0.00131	0.00156	CcSEcCtD
Maraviroc—Urine output increased—Methotrexate—colon cancer	0.00131	0.00156	CcSEcCtD
Maraviroc—Alopecia—Irinotecan—colon cancer	0.0013	0.00153	CcSEcCtD
Maraviroc—Orthostatic hypotension—Capecitabine—colon cancer	0.0013	0.00153	CcSEcCtD
Maraviroc—Abdominal pain upper—Capecitabine—colon cancer	0.0013	0.00153	CcSEcCtD
Maraviroc—Breast disorder—Capecitabine—colon cancer	0.00128	0.00152	CcSEcCtD
Maraviroc—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.00128	0.00151	CcSEcCtD
Maraviroc—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.00128	0.00151	CcSEcCtD
Maraviroc—Nasopharyngitis—Capecitabine—colon cancer	0.00127	0.0015	CcSEcCtD
Maraviroc—Flatulence—Irinotecan—colon cancer	0.00126	0.00149	CcSEcCtD
Maraviroc—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00125	0.00148	CcSEcCtD
Maraviroc—Alopecia—Fluorouracil—colon cancer	0.00124	0.00147	CcSEcCtD
Maraviroc—Lymphadenopathy—Methotrexate—colon cancer	0.00124	0.00147	CcSEcCtD
Maraviroc—Abdominal distension—Capecitabine—colon cancer	0.00123	0.00146	CcSEcCtD
Maraviroc—Influenza—Capecitabine—colon cancer	0.00123	0.00145	CcSEcCtD
Maraviroc—Erythema—Fluorouracil—colon cancer	0.00122	0.00145	CcSEcCtD
Maraviroc—Diabetes mellitus—Methotrexate—colon cancer	0.00121	0.00144	CcSEcCtD
Maraviroc—Anaemia—Vincristine—colon cancer	0.00121	0.00143	CcSEcCtD
Maraviroc—Bronchospasm—Capecitabine—colon cancer	0.00121	0.00143	CcSEcCtD
Maraviroc—Polyuria—Methotrexate—colon cancer	0.0012	0.00142	CcSEcCtD
Maraviroc—Angina pectoris—Capecitabine—colon cancer	0.00119	0.00141	CcSEcCtD
Maraviroc—Anaemia—Irinotecan—colon cancer	0.00118	0.0014	CcSEcCtD
Maraviroc—Bronchitis—Capecitabine—colon cancer	0.00118	0.0014	CcSEcCtD
Maraviroc—Hepatic failure—Methotrexate—colon cancer	0.00117	0.00139	CcSEcCtD
Maraviroc—Leukopenia—Vincristine—colon cancer	0.00117	0.00139	CcSEcCtD
Maraviroc—Pancytopenia—Capecitabine—colon cancer	0.00116	0.00138	CcSEcCtD
Maraviroc—Neutropenia—Capecitabine—colon cancer	0.00115	0.00136	CcSEcCtD
Maraviroc—Syncope—Irinotecan—colon cancer	0.00114	0.00135	CcSEcCtD
Maraviroc—Renal failure acute—Methotrexate—colon cancer	0.00114	0.00135	CcSEcCtD
Maraviroc—Leukopenia—Irinotecan—colon cancer	0.00114	0.00135	CcSEcCtD
Maraviroc—Upper respiratory tract infection—Capecitabine—colon cancer	0.00114	0.00135	CcSEcCtD
Maraviroc—Convulsion—Vincristine—colon cancer	0.00114	0.00134	CcSEcCtD
Maraviroc—Anaemia—Fluorouracil—colon cancer	0.00113	0.00134	CcSEcCtD
Maraviroc—Loss of consciousness—Irinotecan—colon cancer	0.00112	0.00133	CcSEcCtD
Maraviroc—Dermatitis exfoliative—Methotrexate—colon cancer	0.00112	0.00132	CcSEcCtD
Maraviroc—Myalgia—Vincristine—colon cancer	0.00112	0.00132	CcSEcCtD
Maraviroc—Cough—Irinotecan—colon cancer	0.00111	0.00132	CcSEcCtD
Maraviroc—Pneumonia—Capecitabine—colon cancer	0.0011	0.0013	CcSEcCtD
Maraviroc—Leukopenia—Fluorouracil—colon cancer	0.00109	0.0013	CcSEcCtD
Maraviroc—Infestation NOS—Capecitabine—colon cancer	0.00109	0.00129	CcSEcCtD
Maraviroc—Infestation—Capecitabine—colon cancer	0.00109	0.00129	CcSEcCtD
Maraviroc—Depression—Capecitabine—colon cancer	0.00109	0.00129	CcSEcCtD
Maraviroc—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00108	0.00128	CcSEcCtD
Maraviroc—Acute coronary syndrome—Capecitabine—colon cancer	0.00108	0.00128	CcSEcCtD
Maraviroc—Cerebrovascular accident—Methotrexate—colon cancer	0.00108	0.00128	CcSEcCtD
Maraviroc—Renal failure—Capecitabine—colon cancer	0.00107	0.00127	CcSEcCtD
Maraviroc—Discomfort—Irinotecan—colon cancer	0.00107	0.00127	CcSEcCtD
Maraviroc—Myocardial infarction—Capecitabine—colon cancer	0.00107	0.00127	CcSEcCtD
Maraviroc—Neuropathy peripheral—Capecitabine—colon cancer	0.00107	0.00127	CcSEcCtD
Maraviroc—Oedema—Vincristine—colon cancer	0.00107	0.00127	CcSEcCtD
Maraviroc—Jaundice—Capecitabine—colon cancer	0.00107	0.00126	CcSEcCtD
Maraviroc—Stomatitis—Capecitabine—colon cancer	0.00107	0.00126	CcSEcCtD
Maraviroc—Infection—Vincristine—colon cancer	0.00106	0.00126	CcSEcCtD
Maraviroc—Conjunctivitis—Capecitabine—colon cancer	0.00106	0.00126	CcSEcCtD
Maraviroc—Convulsion—Fluorouracil—colon cancer	0.00106	0.00125	CcSEcCtD
Maraviroc—Nervous system disorder—Vincristine—colon cancer	0.00105	0.00124	CcSEcCtD
Maraviroc—Oedema—Irinotecan—colon cancer	0.00104	0.00123	CcSEcCtD
Maraviroc—Myalgia—Fluorouracil—colon cancer	0.00104	0.00123	CcSEcCtD
Maraviroc—Infection—Irinotecan—colon cancer	0.00103	0.00123	CcSEcCtD
Maraviroc—Hepatobiliary disease—Capecitabine—colon cancer	0.00103	0.00122	CcSEcCtD
Maraviroc—Discomfort—Fluorouracil—colon cancer	0.00103	0.00122	CcSEcCtD
Maraviroc—Shock—Irinotecan—colon cancer	0.00102	0.00121	CcSEcCtD
Maraviroc—Nervous system disorder—Irinotecan—colon cancer	0.00102	0.00121	CcSEcCtD
Maraviroc—Agranulocytosis—Capecitabine—colon cancer	0.00102	0.00121	CcSEcCtD
Maraviroc—Anorexia—Vincristine—colon cancer	0.00102	0.00121	CcSEcCtD
Maraviroc—Oedema—Fluorouracil—colon cancer	0.000997	0.00118	CcSEcCtD
Maraviroc—Anorexia—Irinotecan—colon cancer	0.000993	0.00118	CcSEcCtD
Maraviroc—Infection—Fluorouracil—colon cancer	0.000991	0.00117	CcSEcCtD
Maraviroc—Rhinitis—Capecitabine—colon cancer	0.000984	0.00116	CcSEcCtD
Maraviroc—Nervous system disorder—Fluorouracil—colon cancer	0.000978	0.00116	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Vincristine—colon cancer	0.000974	0.00115	CcSEcCtD
Maraviroc—Pharyngitis—Capecitabine—colon cancer	0.000974	0.00115	CcSEcCtD
Maraviroc—Urinary tract disorder—Capecitabine—colon cancer	0.000969	0.00115	CcSEcCtD
Maraviroc—Insomnia—Vincristine—colon cancer	0.000967	0.00115	CcSEcCtD
Maraviroc—Connective tissue disorder—Capecitabine—colon cancer	0.000964	0.00114	CcSEcCtD
Maraviroc—Urethral disorder—Capecitabine—colon cancer	0.000962	0.00114	CcSEcCtD
Maraviroc—Paraesthesia—Vincristine—colon cancer	0.00096	0.00114	CcSEcCtD
Maraviroc—Breast disorder—Methotrexate—colon cancer	0.000954	0.00113	CcSEcCtD
Maraviroc—Anorexia—Fluorouracil—colon cancer	0.000951	0.00113	CcSEcCtD
Maraviroc—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000951	0.00113	CcSEcCtD
Maraviroc—Insomnia—Irinotecan—colon cancer	0.000942	0.00112	CcSEcCtD
Maraviroc—Paraesthesia—Irinotecan—colon cancer	0.000935	0.00111	CcSEcCtD
Maraviroc—Decreased appetite—Vincristine—colon cancer	0.00093	0.0011	CcSEcCtD
Maraviroc—Erythema multiforme—Capecitabine—colon cancer	0.000928	0.0011	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Vincristine—colon cancer	0.000923	0.00109	CcSEcCtD
Maraviroc—Fatigue—Vincristine—colon cancer	0.000922	0.00109	CcSEcCtD
Maraviroc—Eye disorder—Capecitabine—colon cancer	0.000917	0.00109	CcSEcCtD
Maraviroc—Pain—Vincristine—colon cancer	0.000915	0.00108	CcSEcCtD
Maraviroc—Constipation—Vincristine—colon cancer	0.000915	0.00108	CcSEcCtD
Maraviroc—Cardiac disorder—Capecitabine—colon cancer	0.000911	0.00108	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000909	0.00108	CcSEcCtD
Maraviroc—Decreased appetite—Irinotecan—colon cancer	0.000905	0.00107	CcSEcCtD
Maraviroc—Eosinophilia—Methotrexate—colon cancer	0.000903	0.00107	CcSEcCtD
Maraviroc—Insomnia—Fluorouracil—colon cancer	0.000902	0.00107	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Irinotecan—colon cancer	0.000899	0.00106	CcSEcCtD
Maraviroc—Fatigue—Irinotecan—colon cancer	0.000898	0.00106	CcSEcCtD
Maraviroc—Paraesthesia—Fluorouracil—colon cancer	0.000896	0.00106	CcSEcCtD
Maraviroc—Pancreatitis—Methotrexate—colon cancer	0.000895	0.00106	CcSEcCtD
Maraviroc—Pain—Irinotecan—colon cancer	0.000891	0.00105	CcSEcCtD
Maraviroc—Constipation—Irinotecan—colon cancer	0.000891	0.00105	CcSEcCtD
Maraviroc—Angiopathy—Capecitabine—colon cancer	0.00089	0.00105	CcSEcCtD
Maraviroc—Mediastinal disorder—Capecitabine—colon cancer	0.000884	0.00105	CcSEcCtD
Maraviroc—Gastrointestinal pain—Vincristine—colon cancer	0.000874	0.00104	CcSEcCtD
Maraviroc—Decreased appetite—Fluorouracil—colon cancer	0.000867	0.00103	CcSEcCtD
Maraviroc—Alopecia—Capecitabine—colon cancer	0.000867	0.00103	CcSEcCtD
Maraviroc—Pancytopenia—Methotrexate—colon cancer	0.000867	0.00103	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000861	0.00102	CcSEcCtD
Maraviroc—Mental disorder—Capecitabine—colon cancer	0.00086	0.00102	CcSEcCtD
Maraviroc—Malnutrition—Capecitabine—colon cancer	0.000854	0.00101	CcSEcCtD
Maraviroc—Erythema—Capecitabine—colon cancer	0.000854	0.00101	CcSEcCtD
Maraviroc—Neutropenia—Methotrexate—colon cancer	0.000853	0.00101	CcSEcCtD
Maraviroc—Pain—Fluorouracil—colon cancer	0.000853	0.00101	CcSEcCtD
Maraviroc—Gastrointestinal pain—Irinotecan—colon cancer	0.000852	0.00101	CcSEcCtD
Maraviroc—Upper respiratory tract infection—Methotrexate—colon cancer	0.000848	0.001	CcSEcCtD
Maraviroc—Body temperature increased—Vincristine—colon cancer	0.000845	0.001	CcSEcCtD
Maraviroc—Abdominal pain—Vincristine—colon cancer	0.000845	0.001	CcSEcCtD
Maraviroc—Flatulence—Capecitabine—colon cancer	0.000842	0.000996	CcSEcCtD
Maraviroc—Abdominal pain—Irinotecan—colon cancer	0.000823	0.000975	CcSEcCtD
Maraviroc—Body temperature increased—Irinotecan—colon cancer	0.000823	0.000975	CcSEcCtD
Maraviroc—Pneumonia—Methotrexate—colon cancer	0.000818	0.000969	CcSEcCtD
Maraviroc—Infestation NOS—Methotrexate—colon cancer	0.000814	0.000963	CcSEcCtD
Maraviroc—Infestation—Methotrexate—colon cancer	0.000814	0.000963	CcSEcCtD
Maraviroc—Depression—Methotrexate—colon cancer	0.000811	0.000961	CcSEcCtD
Maraviroc—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000807	0.000955	CcSEcCtD
Maraviroc—Tremor—Capecitabine—colon cancer	0.0008	0.000947	CcSEcCtD
Maraviroc—Renal failure—Methotrexate—colon cancer	0.0008	0.000947	CcSEcCtD
Maraviroc—Stomatitis—Methotrexate—colon cancer	0.000793	0.000939	CcSEcCtD
Maraviroc—Conjunctivitis—Methotrexate—colon cancer	0.000791	0.000936	CcSEcCtD
Maraviroc—Anaemia—Capecitabine—colon cancer	0.000789	0.000935	CcSEcCtD
Maraviroc—Body temperature increased—Fluorouracil—colon cancer	0.000789	0.000934	CcSEcCtD
Maraviroc—Hypersensitivity—Vincristine—colon cancer	0.000788	0.000933	CcSEcCtD
Maraviroc—Hepatobiliary disease—Methotrexate—colon cancer	0.000769	0.000911	CcSEcCtD
Maraviroc—Hypersensitivity—Irinotecan—colon cancer	0.000767	0.000909	CcSEcCtD
Maraviroc—Asthenia—Vincristine—colon cancer	0.000767	0.000908	CcSEcCtD
Maraviroc—Syncope—Capecitabine—colon cancer	0.000766	0.000907	CcSEcCtD
Maraviroc—Leukopenia—Capecitabine—colon cancer	0.000765	0.000905	CcSEcCtD
Maraviroc—Agranulocytosis—Methotrexate—colon cancer	0.000759	0.000899	CcSEcCtD
Maraviroc—Loss of consciousness—Capecitabine—colon cancer	0.000751	0.000889	CcSEcCtD
Maraviroc—Asthenia—Irinotecan—colon cancer	0.000747	0.000885	CcSEcCtD
Maraviroc—Cough—Capecitabine—colon cancer	0.000745	0.000882	CcSEcCtD
Maraviroc—Hypersensitivity—Fluorouracil—colon cancer	0.000735	0.00087	CcSEcCtD
Maraviroc—Diarrhoea—Vincristine—colon cancer	0.000732	0.000866	CcSEcCtD
Maraviroc—Myalgia—Capecitabine—colon cancer	0.000727	0.000861	CcSEcCtD
Maraviroc—Pharyngitis—Methotrexate—colon cancer	0.000725	0.000858	CcSEcCtD
Maraviroc—Anxiety—Capecitabine—colon cancer	0.000725	0.000858	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000722	0.000855	CcSEcCtD
Maraviroc—Urinary tract disorder—Methotrexate—colon cancer	0.000721	0.000854	CcSEcCtD
Maraviroc—Discomfort—Capecitabine—colon cancer	0.000718	0.000851	CcSEcCtD
Maraviroc—Urethral disorder—Methotrexate—colon cancer	0.000716	0.000848	CcSEcCtD
Maraviroc—Diarrhoea—Irinotecan—colon cancer	0.000713	0.000844	CcSEcCtD
Maraviroc—Dizziness—Vincristine—colon cancer	0.000707	0.000837	CcSEcCtD
Maraviroc—Pruritus—Fluorouracil—colon cancer	0.000706	0.000836	CcSEcCtD
Maraviroc—Oedema—Capecitabine—colon cancer	0.000697	0.000825	CcSEcCtD
Maraviroc—Infection—Capecitabine—colon cancer	0.000692	0.00082	CcSEcCtD
Maraviroc—Erythema multiforme—Methotrexate—colon cancer	0.000691	0.000818	CcSEcCtD
Maraviroc—Dizziness—Irinotecan—colon cancer	0.000689	0.000815	CcSEcCtD
Maraviroc—Shock—Capecitabine—colon cancer	0.000686	0.000812	CcSEcCtD
Maraviroc—Nervous system disorder—Capecitabine—colon cancer	0.000684	0.000809	CcSEcCtD
Maraviroc—Eye disorder—Methotrexate—colon cancer	0.000683	0.000808	CcSEcCtD
Maraviroc—Diarrhoea—Fluorouracil—colon cancer	0.000682	0.000808	CcSEcCtD
Maraviroc—Vomiting—Vincristine—colon cancer	0.00068	0.000805	CcSEcCtD
Maraviroc—Cardiac disorder—Methotrexate—colon cancer	0.000678	0.000803	CcSEcCtD
Maraviroc—Skin disorder—Capecitabine—colon cancer	0.000677	0.000802	CcSEcCtD
Maraviroc—Rash—Vincristine—colon cancer	0.000674	0.000798	CcSEcCtD
Maraviroc—Dermatitis—Vincristine—colon cancer	0.000674	0.000798	CcSEcCtD
Maraviroc—Headache—Vincristine—colon cancer	0.00067	0.000793	CcSEcCtD
Maraviroc—Anorexia—Capecitabine—colon cancer	0.000664	0.000787	CcSEcCtD
Maraviroc—Angiopathy—Methotrexate—colon cancer	0.000663	0.000785	CcSEcCtD
Maraviroc—Vomiting—Irinotecan—colon cancer	0.000662	0.000784	CcSEcCtD
Maraviroc—Dizziness—Fluorouracil—colon cancer	0.00066	0.000781	CcSEcCtD
Maraviroc—Mediastinal disorder—Methotrexate—colon cancer	0.000658	0.000779	CcSEcCtD
Maraviroc—Rash—Irinotecan—colon cancer	0.000657	0.000778	CcSEcCtD
Maraviroc—Dermatitis—Irinotecan—colon cancer	0.000656	0.000777	CcSEcCtD
Maraviroc—Headache—Irinotecan—colon cancer	0.000652	0.000773	CcSEcCtD
Maraviroc—Alopecia—Methotrexate—colon cancer	0.000645	0.000764	CcSEcCtD
Maraviroc—Mental disorder—Methotrexate—colon cancer	0.00064	0.000758	CcSEcCtD
Maraviroc—Malnutrition—Methotrexate—colon cancer	0.000636	0.000753	CcSEcCtD
Maraviroc—Erythema—Methotrexate—colon cancer	0.000636	0.000753	CcSEcCtD
Maraviroc—Nausea—Vincristine—colon cancer	0.000635	0.000752	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000635	0.000752	CcSEcCtD
Maraviroc—Vomiting—Fluorouracil—colon cancer	0.000634	0.000751	CcSEcCtD
Maraviroc—Insomnia—Capecitabine—colon cancer	0.00063	0.000746	CcSEcCtD
Maraviroc—Rash—Fluorouracil—colon cancer	0.000629	0.000745	CcSEcCtD
Maraviroc—Dermatitis—Fluorouracil—colon cancer	0.000628	0.000744	CcSEcCtD
Maraviroc—Paraesthesia—Capecitabine—colon cancer	0.000626	0.000741	CcSEcCtD
Maraviroc—Headache—Fluorouracil—colon cancer	0.000625	0.00074	CcSEcCtD
Maraviroc—Nausea—Irinotecan—colon cancer	0.000619	0.000732	CcSEcCtD
Maraviroc—Decreased appetite—Capecitabine—colon cancer	0.000606	0.000717	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Capecitabine—colon cancer	0.000602	0.000713	CcSEcCtD
Maraviroc—Fatigue—Capecitabine—colon cancer	0.000601	0.000712	CcSEcCtD
Maraviroc—Pain—Capecitabine—colon cancer	0.000596	0.000706	CcSEcCtD
Maraviroc—Constipation—Capecitabine—colon cancer	0.000596	0.000706	CcSEcCtD
Maraviroc—Nausea—Fluorouracil—colon cancer	0.000592	0.000702	CcSEcCtD
Maraviroc—Anaemia—Methotrexate—colon cancer	0.000588	0.000696	CcSEcCtD
Maraviroc—Gastrointestinal pain—Capecitabine—colon cancer	0.00057	0.000675	CcSEcCtD
Maraviroc—Leukopenia—Methotrexate—colon cancer	0.000569	0.000674	CcSEcCtD
Maraviroc—Cough—Methotrexate—colon cancer	0.000555	0.000657	CcSEcCtD
Maraviroc—Abdominal pain—Capecitabine—colon cancer	0.000551	0.000652	CcSEcCtD
Maraviroc—Body temperature increased—Capecitabine—colon cancer	0.000551	0.000652	CcSEcCtD
Maraviroc—Convulsion—Methotrexate—colon cancer	0.000551	0.000652	CcSEcCtD
Maraviroc—Myalgia—Methotrexate—colon cancer	0.000541	0.000641	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000538	0.000636	CcSEcCtD
Maraviroc—Discomfort—Methotrexate—colon cancer	0.000535	0.000633	CcSEcCtD
Maraviroc—Infection—Methotrexate—colon cancer	0.000516	0.00061	CcSEcCtD
Maraviroc—Hypersensitivity—Capecitabine—colon cancer	0.000514	0.000608	CcSEcCtD
Maraviroc—Nervous system disorder—Methotrexate—colon cancer	0.000509	0.000603	CcSEcCtD
Maraviroc—Skin disorder—Methotrexate—colon cancer	0.000504	0.000597	CcSEcCtD
Maraviroc—Asthenia—Capecitabine—colon cancer	0.0005	0.000592	CcSEcCtD
Maraviroc—Anorexia—Methotrexate—colon cancer	0.000495	0.000586	CcSEcCtD
Maraviroc—Pruritus—Capecitabine—colon cancer	0.000493	0.000584	CcSEcCtD
Maraviroc—Diarrhoea—Capecitabine—colon cancer	0.000477	0.000565	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000473	0.00056	CcSEcCtD
Maraviroc—Insomnia—Methotrexate—colon cancer	0.000469	0.000556	CcSEcCtD
Maraviroc—Paraesthesia—Methotrexate—colon cancer	0.000466	0.000552	CcSEcCtD
Maraviroc—Dizziness—Capecitabine—colon cancer	0.000461	0.000546	CcSEcCtD
Maraviroc—Decreased appetite—Methotrexate—colon cancer	0.000451	0.000534	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Methotrexate—colon cancer	0.000448	0.00053	CcSEcCtD
Maraviroc—Fatigue—Methotrexate—colon cancer	0.000447	0.00053	CcSEcCtD
Maraviroc—Pain—Methotrexate—colon cancer	0.000444	0.000525	CcSEcCtD
Maraviroc—Vomiting—Capecitabine—colon cancer	0.000443	0.000525	CcSEcCtD
Maraviroc—Rash—Capecitabine—colon cancer	0.000439	0.00052	CcSEcCtD
Maraviroc—Dermatitis—Capecitabine—colon cancer	0.000439	0.00052	CcSEcCtD
Maraviroc—Headache—Capecitabine—colon cancer	0.000437	0.000517	CcSEcCtD
Maraviroc—Gastrointestinal pain—Methotrexate—colon cancer	0.000424	0.000502	CcSEcCtD
Maraviroc—Nausea—Capecitabine—colon cancer	0.000414	0.00049	CcSEcCtD
Maraviroc—Abdominal pain—Methotrexate—colon cancer	0.00041	0.000486	CcSEcCtD
Maraviroc—Body temperature increased—Methotrexate—colon cancer	0.00041	0.000486	CcSEcCtD
Maraviroc—Hypersensitivity—Methotrexate—colon cancer	0.000382	0.000453	CcSEcCtD
Maraviroc—Asthenia—Methotrexate—colon cancer	0.000372	0.000441	CcSEcCtD
Maraviroc—Pruritus—Methotrexate—colon cancer	0.000367	0.000435	CcSEcCtD
Maraviroc—Diarrhoea—Methotrexate—colon cancer	0.000355	0.00042	CcSEcCtD
Maraviroc—Dizziness—Methotrexate—colon cancer	0.000343	0.000406	CcSEcCtD
Maraviroc—Vomiting—Methotrexate—colon cancer	0.00033	0.000391	CcSEcCtD
Maraviroc—Rash—Methotrexate—colon cancer	0.000327	0.000387	CcSEcCtD
Maraviroc—Dermatitis—Methotrexate—colon cancer	0.000327	0.000387	CcSEcCtD
Maraviroc—Headache—Methotrexate—colon cancer	0.000325	0.000385	CcSEcCtD
Maraviroc—Nausea—Methotrexate—colon cancer	0.000308	0.000365	CcSEcCtD
